The presentation content may contain pipeline updates or financial outlook, but is not readable from this filing. Traders should monitor the investor relations page for the actual presentation or any subsequent material updates via separate 8-K or press release.
Price Chart
Executive Summary
Dare Bioscience filed an 8-K to furnish a corporate investor presentation dated July 13, 2026, as Exhibit 99.1. The document content is not readable (binary/encoded graphics), so no new financial data or material updates can be extracted from the filing. This is a routine Regulation FD disclosure with no immediate market-moving information visible.
Key Facts
- 8-K filed July 13, 2026, under Items 7.01 (Regulation FD) and 9.01 (Financial Statements and Exhibits)
- Exhibit 99.1 contains a corporate presentation, but the text is encoded and unreadable in the filing
- Presentation will be used in meetings with market participants and will be posted on the company's website
- No financial figures, guidance, or material events are disclosed in the 8-K itself
Financial Impact
No quantifiable impact — filing is a routine investor presentation without extractable financial data
Risk Factors
- Presentation may contain negative pipeline or financial updates that are not visible in this filing
- Low confidence due to unreadable exhibit content
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-032963 |
| Document: form8-k.htm | 0001493152-26-032963 |
| Document: 0001493152-26-032963-index-headers.html | 0001493152-26-032963 |
| Document: 0001493152-26-032963-index.html | 0001493152-26-032963 |
| Document: 0001493152-26-032963.txt | 0001493152-26-032963 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 19d ago | DEF 14A | $0.7900 $0.7720 | ▲ +2.28% | ▲ +1.86% | $0.6467 (+18.14%) |
Oct 1, 2026 25d ago | 8-K | $0.8510 $0.8428 | ▼ −0.96% | ▼ −1.70% | $0.6467 (−24.01%) |
Sep 9, 2026 6w ago | 8-K | $0.7166 $0.7051 | ▼ −1.60% | ▼ −1.01% | $0.6467 (−9.75%) |
Sep 4, 2026 7w ago | EFFECT | $0.7210 $0.7130 | ▲ +1.11% | ▲ +0.56% | $0.6467 (+10.31%) |
Aug 17, 2026 10w ago | 8-K | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 17, 2026 10w ago | 424B5 | $0.8102 $0.7682 | ▲ +5.18% | ▲ +4.51% | $0.6467 (+20.18%) |
Aug 13, 2026 10w ago | 8-K | $0.9300 $0.8102 | ▼ −12.88% | ▼ −12.41% | $0.6467 (−30.46%) |
Aug 6, 2026 11w ago | Press Release | $1.33 $1.40 | ▲ +5.26% | ▲ +4.65% | $0.6467 (−51.38%) |
Jul 24, 2026 13w ago | 8-K | $1.28 $1.32 | ▲ +3.13% | ▲ +3.10% | $0.6467 (−49.48%) |
Jul 13, 2026 15w ago | 8-K | $2.09 $2.07 | ▼ −0.96% | ▼ −1.31% | $0.6467 (−69.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers